BIOtech Now Coverage of the Convention

Announcing the Buzz of BIO Winner for Pipelines of Promise!

Publish Date: 5/15/2012, Created By: Sondra Behan

We’re very pleased to announce the Buzz of BIO Winner for the 2012 contest of the BIO International Convention. You voted for your favorites, and it was a tight, interesting race! As such, we’re pleased to introduce you to our winner for the Pipelines of Promise category. Deuteria Pharmaceuticals, Inc,. who focuses on improving the product profile of approved drugs through ‘chiral switching’, won the Pipelines of Promise category. From Dr. Sheila DeWitt, the company’s Read More >

myBIO and One-on-One Partnering… What’s the Difference?

Publish Date: 5/14/2012, Created By: Sondra Behan

This June, thousands will gather in the biotech hub of Boston! One of the things the team has been hard at work on, is the online community of myBIO, as those who have attended the Convention in the past will recognize. It’s a very handy, interactive tool that allows you to track companies, communicate with other attendees, and get a bird’s-eye view of all the different events going on. As a registrant, you even have Read More >

Industry Regulatory Issues to be Highlighted at 2012 BIO International Convention

Publish Date: 5/9/2012, Created By: Abigail Hirsch

In the words of BIO’s Andrew Emmett, Managing Director, Science & Regulatory Affairs, ‘2012 is shaping up to be a momentous year for FDA reform.’ From the reauthorization of the Prescription Drug User Fee Act (PDUFA V) to modernizing and expediting the approval of new drugs and biologics, implementing the new biosimilars pathways and addressing the growing global drug shortage crisis, all eyes are on the current regulatory environment and its role in supporting innovation. Read More >

BIO Convention 2012: Biotech IP and Tech Transfer Sessions

Publish Date: 4/17/2012, Created By: Roy Zwahlen

Recent court decisions and ongoing implementation of the America Invents Act are certain to impact the life sciences industry. The 2012 BIO International Convention will feature an educational track devoted to Biotech Patenting and Tech Transfer to discuss legal and legislative developments and how they are likely to impact biotech companies.   This year’s global event for biotechnology will take place June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA. Recent Developments Read More >

Partnering Launches for the International Convention

Publish Date: 4/11/2012, Created By: Sondra Behan

It’s here folks! The One-on-One Partnering™ System for this year’s BIO Business Forum® and Exhibitor Partnering has officially launched! What does that mean? If you’re registered for the event, you’ll be receiving your login credentials shortly. If you’re not registered, you should do that now, so you can get in to the system. From there, you can start building your company’s profile, search for companies, and send your targeted meeting requests. This year, we’re pleased Read More >

April 11th Webinar: Expanded Partnering

Publish Date: 4/6/2012, Created By: Sondra Behan

Join us for Part 3 of the 4 webinar series outlining NEW exhibitor booth partnering, One-on-One System enhancements, and how to get more ROI using partnering at the 2012 BIO International Convention. Unlock the Power of Partnering: Webinar & Discussion on Expanded Partnering and Tips for Partnering Success at BIO Wednesday, April 11th 11:00 am – 12:00 pm ET RSVP Here This partnering webinar will cover the following: New in 2012: Expanded Opportunities with Exhibitor Read More >

2012 Orphan Disease Forum: Addressing Today’s Opportunities and Challenges

Publish Date: 4/6/2012, Created By: Abigail Hirsch

If all of the people with rare disease lived in one country, it would be the world’s third most populous country! Through dedicated companies such as the National Organization for Rare Disorders (NORD) and Centric Health Resources, the pressing issue of orphan diseases and its patients are being addressed. A rare disease is defined by any disease affecting fewer than 200,000 Americans. There are nearly 7,000 such diseases affecting over 350 million people worldwide.  Furthermore, Read More >

2012 MassBioEd Innovative School of the Year – Norton High School

Publish Date: 4/5/2012, Created By: Abigail Hirsch

Massachusetts is home to the full ecosystem of life sciences—including our world class academic institutions and medical centers, a vibrant venture capital community, hundreds of biotech companies of all sizes, contract research and manufacturing organizations, and service organizations supporting the industry. It is no wonder then that eleven years ago MassBio established the Massachusetts Biotechnology Foundation to promote biotechnology education and workforce development programs. Each year, the Foundation awards the Innovative School of the Year Read More >

Abbott Laboratories: Keys for Partnering Success at the BIO International Convention

Publish Date: 3/29/2012, Created By: Abigail Hirsch

Thinking of hosting pre-qualified meetings at your BIO Exhibition booth during the 2012 BIO International Convention? Abbott Laboratories did just that at last year’s Convention and learned what it takes to succeed and secure high-quality leads. “The greatest value of partnering within our booth is that it allows us to drive traffic, activity and interest within our booth space,” said Michelle Calhoun, Abbott’s contract manufacturing sales and marketing director. During the 2011 Convention, Abbott hosted Read More >

2012 Biotech Humanitarian Award Nominations Open

Publish Date: 3/22/2012, Created By: Abigail Hirsch

BIO is now accepting nominations for the fourth annual Biotech Humanitarian Award. The Award will be given to an individual who, through their work in or support of biotechnology, is harnessing its potential to heal, fuel or feed the planet. The Humanitarian Award honors work that aims to reduce human suffering significantly or enhance the human experience in a way that has a clear and direct benefit to society.  Additional consideration will be given to Read More >